These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 26210995)

  • 21. CWP232228 targets liver cancer stem cells through Wnt/β-catenin signaling: a novel therapeutic approach for liver cancer treatment.
    Kim JY; Lee HY; Park KK; Choi YK; Nam JS; Hong IS
    Oncotarget; 2016 Apr; 7(15):20395-409. PubMed ID: 26967248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting crosstalk of signaling pathways in cancer stem cells: a promising approach for development of novel anti-cancer therapeutics.
    Bhal S; Kundu CN
    Med Oncol; 2023 Jan; 40(2):82. PubMed ID: 36662310
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of epigenetic modulation in cancer stem cell fate.
    Deshmukh A; Binju M; Arfuso F; Newsholme P; Dharmarajan A
    Int J Biochem Cell Biol; 2017 Sep; 90():9-16. PubMed ID: 28711634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Wnt/β-catenin signalling maintains self-renewal and tumourigenicity of head and neck squamous cell carcinoma stem-like cells by activating Oct4.
    Lee SH; Koo BS; Kim JM; Huang S; Rho YS; Bae WJ; Kang HJ; Kim YS; Moon JH; Lim YC
    J Pathol; 2014 Sep; 234(1):99-107. PubMed ID: 24871033
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evodiamine Eliminates Colon Cancer Stem Cells via Suppressing Notch and Wnt Signaling.
    Kim H; Yu Y; Choi S; Lee H; Yu J; Lee JH; Kim WY
    Molecules; 2019 Dec; 24(24):. PubMed ID: 31835579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting the crosstalks of Wnt pathway with Hedgehog and Notch for cancer therapy.
    Chatterjee S; Sil PC
    Pharmacol Res; 2019 Apr; 142():251-261. PubMed ID: 30826456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of combination of notch inhibitor plus hedgehog inhibitor or Wnt inhibitor on growth of leukemia cells.
    Okuhashi Y; Itoh M; Nara N; Tohda S
    Anticancer Res; 2011 Mar; 31(3):893-6. PubMed ID: 21498710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting embryonic signaling pathways in cancer therapy.
    Harris PJ; Speranza G; Dansky Ullmann C
    Expert Opin Ther Targets; 2012 Jan; 16(1):131-45. PubMed ID: 22239436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer stem cell epigenetics and chemoresistance.
    Crea F; Danesi R; Farrar WL
    Epigenomics; 2009 Oct; 1(1):63-79. PubMed ID: 22122637
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of Mel-18 enhances breast cancer stem cell activity and tumorigenicity through activating Notch signaling mediated by the Wnt/TCF pathway.
    Won HY; Lee JY; Shin DH; Park JH; Nam JS; Kim HC; Kong G
    FASEB J; 2012 Dec; 26(12):5002-13. PubMed ID: 22954590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hedgehog and Notch signaling regulate self-renewal of undifferentiated pleomorphic sarcomas.
    Wang CY; Wei Q; Han I; Sato S; Ghanbari-Azarnier R; Whetstone H; Poon R; Hu J; Zheng F; Zhang P; Wang W; Wunder JS; Alman BA
    Cancer Res; 2012 Feb; 72(4):1013-22. PubMed ID: 22232736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New approaches to target cancer stem cells: current scenario.
    Insan MB; Jaitak V
    Mini Rev Med Chem; 2014 Jan; 14(1):20-34. PubMed ID: 24195662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emerging agents that target signaling pathways in cancer stem cells.
    Yang Y; Li X; Wang T; Guo Q; Xi T; Zheng L
    J Hematol Oncol; 2020 May; 13(1):60. PubMed ID: 32456660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gastric cancer stem cells: therapeutic targets.
    Stojnev S; Krstic M; Ristic-Petrovic A; Stefanovic V; Hattori T
    Gastric Cancer; 2014 Jan; 17(1):13-25. PubMed ID: 23563919
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer stem cells (CSCs) in cancer progression and therapy.
    Najafi M; Farhood B; Mortezaee K
    J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting a Lipid Desaturation Enzyme, SCD1, Selectively Eliminates Colon Cancer Stem Cells through the Suppression of Wnt and NOTCH Signaling.
    Yu Y; Kim H; Choi S; Yu J; Lee JY; Lee H; Yoon S; Kim WY
    Cells; 2021 Jan; 10(1):. PubMed ID: 33430034
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibiting WNT and NOTCH in renal cancer stem cells and the implications for human patients.
    Fendler A; Bauer D; Busch J; Jung K; Wulf-Goldenberg A; Kunz S; Song K; Myszczyszyn A; Elezkurtaj S; Erguen B; Jung S; Chen W; Birchmeier W
    Nat Commun; 2020 Feb; 11(1):929. PubMed ID: 32066735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cancer stem cells: characteristics and their potential role for new therapeutic strategies.
    Bohl SR; Pircher A; Hilbe W
    Onkologie; 2011; 34(5):269-74. PubMed ID: 21577035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Canonical and non-canonical WNT signaling in cancer stem cells and their niches: Cellular heterogeneity, omics reprogramming, targeted therapy and tumor plasticity (Review).
    Katoh M
    Int J Oncol; 2017 Nov; 51(5):1357-1369. PubMed ID: 29048660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differentiation pathways in carcinogenesis and in chemo- and radioresistance.
    Janikova M; Skarda J
    Neoplasma; 2012; 59(1):6-17. PubMed ID: 22017591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.